Perfil
Pascal Birman is currently the Chief Medical Officer at PHAXIAM Therapeutics SA since 2023.
Prior to this, he worked as the Medical Director at Pherecydes Pharma SA and as the Deputy Chief Medical Officer at Genfit SA.
Cargos activos de Pascal Birman
| Empresas | Cargo | Inicio |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 23/06/2023 |
Antiguos cargos conocidos de Pascal Birman.
| Empresas | Cargo | Fin |
|---|---|---|
| GENFIT | Corporate Officer/Principal | - |
| PHERECYDES PHARMA | Chief Tech/Sci/R&D Officer | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GENFIT | Health Technology |
| PHAXIAM THERAPEUTICS S.A. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
- Bolsa de valores
- Insiders
- Pascal Birman
